
Keywords: Transcriptomics, scRNAseq, PANoptosis, metabolomics, organ preservation solution, EVLP perfusion solution
Mingyao Liu, MD
James and Mary Davie Chair in Lung Injury, Repair and Regeneration, TGHRI, UHN
Professor of Surgery, Director of Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto
The current research in my lab focusing on cellular and molecular mechanisms of ischemia reperfusion injury in lung transplantation. Using transcriptomics, metabolomics and bioinformatics we are studying the role of different types of cell death and metabolic changes in donor lungs. Using cell culture and animal models, we are developing new organ preservation solution and EVLP perfusion solution.





